Document is current
Any future updates will be listed below
-
Authors
Kirby, Bryce
Di Bernardo, Matteo
Cheeseman, Iain M.
Blainey, Paul C.
-
Funding
Funding for this research was provided by:
National Science Foundation
National Institutes of Health (R35GM126930)
National Institutes of Health (P01AI120943-06A1)
Chan Zuckerberg Initiative (2023-332277)
Chan Zuckerberg Initiative (2023-332286)
Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology
Broad Institute
Massachusetts Institute of Technology
- License Information
-
More Information
Article History
Received: 2 April 2026
Accepted: 17 June 2026
First Online: 3 July 2026
Declarations
:
: Not applicable.
: Not applicable.
: PCB serves as a consultant to or equity holder in several companies including 10X Technologies/10X Genomics, GALT/Isolation Bio, Next Gen Diagnostics, Cache DNA, Concerto Biosciences, Stately Bio, Ramona Optics, Bifrost Biosystems, and Amber Bio. PCB's lab has received funding from Calico Life Sciences, Merck, and Genentech for research related to optical pooled screens.
